Morgan Stanley Upgrades Edwards Lifesciences To Overweight

Loading...
Loading...
Morgan Stanley upgraded
Edwards Lifesciences CorpEW
from Equal-weight to Overweight. The price target for Edwards Lifesciences has been raised from $135.00 to $168.00. Edwards Lifesciences shares have gained 62.93 percent over the past 52 weeks, while the S&P 500 index has surged 5.01 percent in the same period. Edwards Lifesciences' shares fell 0.01 percent to close at $142.44 on Thursday.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesAnalyst RatingsMorgan Stanley
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...